4/16
01:18 pm
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/22
10:24 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
3/22
10:24 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
3/21
11:13 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.